New test helps doctors predict a dangerous side effect of cancer treatment

Medical researchers in Japan have discovered a way to predict a potentially life-threatening side effect of cancer immunotherapy before it occurs. By analyzing cerebrospinal fluid collected pre-treatment, researchers at Kyushu University identified specific proteins associated with a damaging immune response that can affect the central nervous system after therapy.

Headways and hurdles: How AI is shaping the future of medicine

Artificial Intelligence (AI) is poised to revolutionize numerous aspects of human life, with health care among the most critical fields set to benefit from this transformation. Medicine is a complex, costly and high-impact field, facing challenges in data management, diagnostics and cost reduction. AI offers solutions to these issues, enhancing care and cutting costs. However, its adoption lags behind other industries, underscoring the need to address key barriers.

Q&A: How caseload pressures can contribute to mischaracterizing ‘medical invalidation’ as ‘gaslighting’

Patients struggling with hard-to-detect conditions, such as long COVID; or with symptoms whose causes modern medical testing has trouble pinning down, such as irritable bowel syndrome, can feel dismissed when a doctor says they can’t find a cause for the ailment, or—worse—when they suggest that the condition may be all in the patient’s head. This is commonly known as “medical gaslighting,” a problem that is hardly new but one that social media has amplified in recent years.

Quercetin: A natural solution with the potential to combat liver fibrosis

Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral hepatitis, alcohol-related liver disease, and non-alcoholic fatty liver disease (NAFLD). If left untreated, it can progress to cirrhosis, liver cancer, or even liver failure, significantly increasing the risk of severe complications and mortality.

Receiving low-glucose alerts can improve diabetic drivers’ safety on the road

A Japanese study conducted by a team from Nagoya University Graduate School of Medicine found that the use of continuous glucose monitoring (CGM) devices, equipped with sensors that alert diabetics when their blood sugar levels drop, can potentially make diabetic drivers safer on the road. Those who used such devices had lower incidences of low blood sugar and reported increased confidence in driving. The findings are published in Diabetes Research and Clinical Practice.